Get started
Author

Philipp Kramer

Observed names: P Kramer, P. Kramer
ORCID: 0000-0003-3998-285X
Observed ORCID: 0000-0003-3998-285X
OpenAlex ID: A5044204479
M1-like, but not M0- or M2-like, macrophages, reduce RSV infection of primary bronchial epithelial cells in a media-dependent fashion
2022 · Natalie J. Ronaghan, Mandy Soo, et al. · PLoS ONE · 20
PDF
Generation of apical-out nasal organoids to facilitate human respiratory syncytial virus infection and drug screening
2026 · Georgios Stroulios, Mathieu Hubert, et al. · iScience · 1
Poster: 319From progenitor expansion to functional models: a standardized workflow for scaling human airway epithelial cultures
2026 · N. Ronaghan, T. Brown, et al. · Journal of Cystic Fibrosis
C70-25 Optimized Culture of Human Nasal Epithelial Cells Maintains CFTR Function for Drug Screening Applications
2026 · P Kramer, N Potter, et al. · American Journal of Respiratory and Critical Care Medicine
178 Next-generation medium enhances airway epithelial cell long-term expansion capacity and differentiation potential
2025 · T. Brown, N. Ronaghan, et al. · Journal of Cystic Fibrosis
EPS3.07Functional rescue of the I506T-CFTR variant by CFTR modulator combination therapies in human nasal epithelial cell-derived air-liquid interface cultures
2025 · N. Potter, L. Davis, et al. · Journal of Cystic Fibrosis
190 Generation of fully differentiated and functional human small airway cultures
2023 · T. Brown, M. Tellis, et al. · Journal of Cystic Fibrosis
PDF
451 Robust, efficient workflow to establish, culture, and functionally assess primary-isolated airway epithelial cells
2022 · T. Brown, R. Swayze, et al. · Journal of Cystic Fibrosis
PDF
Works count: 8
Citation count: 21
H-index: 1
I10-index: 1
Year
Topic
Type